A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models-Reference-Cited by-同舟云学术

A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models

Published:2009-07 Issue:7 Volume:60 Page:2008-2018
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Baragi Vijaykumar M.,Becher Gabriel,Bendele Alison M.,Biesinger Ralf,Bluhm Harald,Boer Jürgen,Deng Hongbo,Dodd Rory,Essers Michael,Feuerstein Tim,Gallagher Brian M.,Gege Christian,Hochgürtel Matthias,Hofmann Michael,Jaworski Andreas,Jin Lixia,Kiely Andrew,Korniski Brian,Kroth Heiko,Nix Darrell,Nolte Bert,Piecha Dorothea,Powers Timothy S.,Richter Frank,Schneider Matthias,Steeneck Christoph,Sucholeiki Irving,Taveras Arthur,Timmermann Andreas,Van Veldhuizen Joshua,Weik Juergen,Wu Xinyuan,Xia Bing

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24629/fullpdf

Reference39 articles.

1. New functions for the matrix metalloproteinases in cancer progression;Egeblad;Nat Rev Cancer,2002

2. Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis;Aranapakam;J Med Chem,2003

3. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis;Sabatini;Arthritis Rheum,2005

4. Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis;Brewster;Arthritis Rheum,1998

5. Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines;Natchus;J Med Chem,2000

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics;Annals of Medicine & Surgery;2024-06-04

2. Screening of MMP-13 Inhibitors Using a GelMA-Alginate Interpenetrating Network Hydrogel-Based Model Mimicking Cytokine-Induced Key Features of Osteoarthritis In Vitro;Polymers;2024-06-01

3. Application of amniotic membrane in osteoarthritis management;Journal of Cartilage & Joint Preservation;2024-03

4. On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis;Journal of Materials Chemistry B;2024

5. Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease;International Journal of Molecular Sciences;2023-12-04